- Report
- April 2022
- 191 Pages
Global
From €3077EUR$3,185USD£2,631GBP
€4395EUR$4,550USD£3,758GBP
- Report
- March 2021
Global
From €3077EUR$3,185USD£2,631GBP
€4395EUR$4,550USD£3,758GBP
- Report
- March 2020
- 135 Pages
Europe
From €2029EUR$2,100USD£1,735GBP
€2898EUR$3,000USD£2,478GBP
- Report
- March 2020
- 137 Pages
Asia Pacific
From €2029EUR$2,100USD£1,735GBP
€2898EUR$3,000USD£2,478GBP
- Report
- March 2020
- 126 Pages
North America
From €2029EUR$2,100USD£1,735GBP
€2898EUR$3,000USD£2,478GBP
- Report
- February 2020
- 144 Pages
Global
From €3077EUR$3,185USD£2,631GBP
€4395EUR$4,550USD£3,758GBP
- Report
- April 2023
- 115 Pages
Global
From €4588EUR$4,750USD£3,923GBP
- Report
- January 2022
- 115 Pages
Global
From €4588EUR$4,750USD£3,923GBP
- Report
- April 2023
- 240 Pages
Global
From €3381EUR$3,500USD£2,891GBP
- Report
- August 2022
- 30 Pages
Global
From €2656EUR$2,750USD£2,271GBP
- Report
- January 2022
- 60 Pages
Global
From €3816EUR$3,950USD£3,263GBP
- Report
- October 2023
- 71 Pages
India
From €3381EUR$3,500USD£2,891GBP
- Report
- June 2022
- 95 Pages
Global
From €3816EUR$3,950USD£3,263GBP
- Report
- January 2022
- 200 Pages
Global
From €7245EUR$7,500USD£6,195GBP
- Report
- January 2022
- 200 Pages
Global
From €7245EUR$7,500USD£6,195GBP
- Report
- November 2022
- 100 Pages
Global
From €2656EUR$2,750USD£2,271GBP
- Report
- July 2022
- 100 Pages
Global
From €2656EUR$2,750USD£2,271GBP
- Report
- April 2024
- 115 Pages
From €4347EUR$4,500USD£3,717GBP
- Report
- August 2022
- 120 Pages
Global
From €4347EUR$4,500USD£3,717GBP
- Report
- November 2021
- 101 Pages
Global
From €4347EUR$4,500USD£3,717GBP
The Asthma Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of medications used to treat asthma. Asthma is a chronic respiratory condition that affects the airways, causing difficulty breathing, coughing, and wheezing. Asthma drugs are designed to reduce inflammation in the airways, making it easier for patients to breathe. These drugs can be taken orally, inhaled, or injected, depending on the severity of the condition. Common asthma drugs include corticosteroids, bronchodilators, and leukotriene modifiers.
Some of the major companies in the Asthma Drugs market include GlaxoSmithKline, Merck & Co., Novartis, Pfizer, and Sanofi. These companies are involved in the research, development, and marketing of asthma drugs, as well as the production of generic versions of existing drugs. They also provide support services to patients, such as educational materials and access to specialists. Show Less Read more